STRS Ohio’s GenMark Diagnostics, Inc GNMK Stock Holding History

STRS Ohio’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-13,600	Closed	-$146K	–	1942
2013 Q2	$141K	Buy	+13,600	New	+$188K	﹤0.01%	1574

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

STRS Ohio's GNMK Position: Q3 2013 in Review

STRS Ohio sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2013, closing a stake of 13,600 shares — an estimated $146K sold.

STRS Ohio first reported a position in GNMK in Q2 2013 and held it in 1 quarter. The position peaked at $141K in Q2 2013. 73 funds tracked by Wall St. Rank hold GNMK as of Q3 2013.

STRS Ohio reported no remaining GenMark Diagnostics, Inc position as of Q3 2013 after selling out during the quarter.
STRS Ohio sold 13,600 GenMark Diagnostics, Inc shares in Q3 2013, an estimated $146K.
STRS Ohio first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 1 quarter.
STRS Ohio's GenMark Diagnostics, Inc position peaked at $141K in Q2 2013.
73 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2013.

Based on STRS Ohio's 13F filing for Q3 2013, filed 24 Oct 2013.